Overview

Industrial biotechnology is undergoing a step change in capability with many new start-ups. However, many of the new start-ups have bemoaned the lack of scale-up capability in the UK, despite a number of initiatives such as CPI Wilton, IBioIC, and BioPilots, with a number of them using overseas capacity.

This event will examine whether sufficient scale-up capacity exists in the UK for start-up industrial biotech companies. This will be in the context of the experience of a variety of companies as they have transitioned from laboratory to pilot plant and on to manufacture.

We will be particularly looking at the food, enzyme, fine chemicals, and oral pharmaceuticals portions of the sector (not the large scale energy sector).

This meeting, which starts at midday on 26 November and finishes early afternoon on 27 November will feature some evening entertainment/networking, and is open to all. It offers a programme of invited talks, exhibits, and an interactive workshops session.

Intended audience

Engineers and scientists working in the industrial biotechnology sector.